Desmoid Fibromatosis

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

SpringWorks Therapeutics
1 program
1
Biospecimen CollectionPhase 21 trial
Active Trials
NCT04195399Active Not RecruitingEst. Dec 2032

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
SpringWorks TherapeuticsBiospecimen Collection

Clinical Trials (1)

NCT04195399SpringWorks TherapeuticsBiospecimen Collection

A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

Start: Oct 2020Est. completion: Dec 2032
Phase 2Active Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space